Hyundai Pharmaceutical Co., Ltd. (KRX:004310)

South Korea flag South Korea · Delayed Price · Currency is KRW
14,340
+1,220 (9.30%)
At close: Feb 13, 2026
Market Cap396.90B +301.1%
Revenue (ttm)108.14B +5.8%
Net Income1.41B
EPS60.34
Shares Out27.68M
PE Ratio237.66
Forward PEn/a
Dividend30.00 (0.21%)
Ex-Dividend DateMar 3, 2026
Volume19,674,170
Average Volume4,766,671
Open13,530
Previous Close13,120
Day's Range13,200 - 15,960
52-Week Range2,995 - 15,960
Beta0.82
RSI68.10
Earnings Daten/a

About Hyundai Pharmaceutical

Hyundai Pharmaceutical Co., Ltd. manufactures and distributes pharmaceutical products, health food drinks, and medical devices in South Korea and internationally. The company offers a range of ETC and OTC products in various therapeutic areas, including antianginal, antibiotic, antiemetics+antinauseants, antihistamines and antiallergics, antihyperlipidemic, antihypertensive, antiplatelet agent, antitussives, cell stimulants and proliferants, central nervous system, depilatory, dermatological agent, dermatology, dietary supplements, digestive sy... [Read more]

Sector Healthcare
Founded 1965
Employees 393
Stock Exchange Korea Stock Exchange
Ticker Symbol 004310
Full Company Profile

Financial Performance

Financial Statements